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Abstract 
Introduction: Cytokines are the important factors in the progression of periodontal diseases. The aim of this 
study was to find out the effect of the first phase of the periodontal therapy on the amount of existing IL-17 
and IL-23 in gingival crevicular fluid in patients with severe periodontitis and in the control group. 
Methods: In this clinical trial intervention study,after purifying the parts which were under consideration in 
22 patients with severe periodontitis, gingival crevicular fluid was gathered using periopaper located within 
the gingival sulcus, Then, the first phase of periodontal therapy was carried out and sample taking from the 
same parts was conducted after 4 weeks. The same phase was carried out on 24 healthy patients (control 
group). All patients were selected from the Department of Periodontology, Tehran Islamic Azad University 
Dental Branch. Since the data did not have a normal distribution, therefore, nonparametric tests were used for 
comparing the groups (Mann-Whitney U Test). A p≤0.05 is considered as significant. 
Results: The results showed that there was a meaningful and significant difference between the IL-17 
viscosity before (p<0005) and after (p<005) the therapy and IL-23 viscosity before (p<0001) and after 
(p<001) the therapy between the two groups. 
Conclusions: According to the results of the present study, we can conclude that IL-17 and IL-23 have a 
significant role in the pathogeneses of periodontal disease. 
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 مايع شيار 23ي17زايل درمان پريًدوتال برميسان ايىترلًکيه های تاثيرفا
 لثه ای بيماران دارای پريًدوتيت شديد 
 
َدف ازایه مطالعٍ تعییه تاثیرفازايل  سایتًکایه َا فاکتًرَای مُمی درپیطرفت بیماری َای پریًدوتال َستىد. :مقدمه
 گريٌ کىترل  ي یارلثٍ ای بیماران دارای پریًدوتیت ضدیدمایع ض 23ي17درمان پریًدوتال برمیسان ایىترلًکیه َای 
 .باضد می
دارای  بیمار 33لثٍ ای  مطالعٍ ضدٌ يمایع ضیار پس ازپرکردن فرم رضایتىامٍ بیماران ياجد ضرایط يارد ها: ريش ي مًاد
فاز ايل درمان  َفتٍ پس از اوجام 4. جمع آيری ضد repapoirep(گريٌ کىترل) تًسط  بیمارسالم 33 پریًدوتیت ي
بٍ آزمایطگاٌ  ASILEپریًدوتال ضامل جرم گیری ي آمًزش بُداضت ديبارٌ ومًوٍ گیری اوجام ضدٌ ي برای اوجام تست 
 فرستادٌ ضد.
ي ) 500<p ( از درمان پریًدوتال ي بعد)  5000<pقبل ( 17وتایج وطان دادود کٍ میسان ایىترلًکیه  يافته ها:
 ) بیه دي گريٌ تغییر می یابد.100<p) ي بعد از درمان(1000<pقبل ( 23ایىترلًکیه 
وقص مُمی درپیطرفت  23ي17براساس یافتٍ َای ایه مطالعٍ می تًان وتیجٍ گرفت کٍ ایىترلًکیه َای  وتيجه گيری:
 .بیماری پریًدوتال دارود
 23، ایىترلًکیه 17پریًدوتیت ضدید، ایىترلًکیه  ياشگان کليدی:
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Introduction 
Periodontitis is the inflammation of tooth 
supporting tissues caused by a special group of 
microorganisms; it can lead to the progressive 
degeneration of periodontal ligament and alveolar bone 
loss, gingival recession or both by pocket formation, 
following the stimulation of the immune-system 
products or lack of therapy. Bacterial products can also 
cause tissue degeneration by affecting the immune 
system. Periodontal evaluation and treatment results 
are usually performed by clinical and radiographic 
examinations.  
Investigating factors like pocket depth (PD), 
bleeding on probing (BOP) and the height of the 
alveolar bone crest are the common ways of evaluating 
periodontitis. The value of the present criteria has been 
questioned due to the recent progress in the 
pathogenesis of periodontal disease and the 
identification of immunologic factors. Some of the new 
methods of diagnosis are finding specific 
microorganisms in GCF, evaluating the nature of host 
response in serum, GCF, saliva, etc. 
The products of the inflammatory response, 
including PMN cells, appear in the gingival crevicular 
fluid; the periodontium cells are influenced by 
pathogenic factors like cytokines, prostaglandins and 
periodontal pathogenic bacteria (1). Cytokines are the 
important factors in the progression of periodontal 
disease. The sources of cytokines are monocytes, 
macrophages and PMNs; they are the important parts 
of the defense system against bacterial lipopolysacaride 
and have important role in activating macrophages and 
differentiating CD8 and CD4.  
It is generally agreed that the balance control 
between CD8 and CD4 (T-helper1 & T-helper2) plays 
a central role in the development of immunity in 
periodontal diseases. Th1 and Th2 products cause 
cellular and hemoral responses, respectively. In 
primary periodontal lesions, the Th1 cells slightly 
increase while advanced lesions tend to shift to Th2 
cells (2). IL-17 is the product of Th1 and IL-23 is the 
product of macrophages and dendritic cells (3).  
Considering the relationship between the two 
interleukins, it is expected that following the 
periodontitis progression, their rates change, as well. 
IL-23 is a heterodimer consisting of a single 19Kd 
(p19) chain paired with p40 protein of IL-12. This 
interleukin is produced by macrophages and dendritic 
cells in response to microbial infections. IL-23 
receptors exist on T cells and natural killer cells 
(NKCs). Recent studies have shown that IL-23 has a 
significant role in resistance against some gram 
negative bacteria like klebsiella pneumonia. 
Stimulation and differentiation of T cells is a way 
through which IL-23 affects autoimmune responses.  
IL-17 includes a family of 6 cytokines which are 
structurally interrelated. Some of these factors can 
cause tissue degeneration and hypersensitivity 
reactions and some others have significant role in 
resisting bacterial infections. The structure of these 
cytokines and their receptors is not the same and is 
different. IL-17A, F is one of the most specific 
members of this group and is produced by different 
cells including T-helper 1, 2 and T cell CD4
+
. The 
distinction and durability of this interleukin depends on 
TGFß, IL-23 and cytokines that are generated during 
the immune response (IL-6).  
IL-17 A, F affect endothelial cells and macrophages 
and lead to the generation of IL-1, TNFβ and other 
chemokines. It also causes the generation of 
hematopoietic cytokines which stimulate the 
production of neutrophils. It seems that interleukin 17, 
generated by T-cells, is an important index of tissue 
destruction in autoimmune diseases (3). 
In the study of Takashi et al. it is mentioned that the 
amount of IL-17 in GCF of the patients with acute 
periodontitis increases (4); however, in the study of  
Vernal et al, it is said that the amount of this 
interleukin decreases under the same conditions (5). 
Considering the disagreements and lack of sufficient 
studies, particularly in Iran, the aim of present study 
was to compare the change in the amounts of IL-23 and 
IL-17 in the gingival crevicular fluid of patients with 
acute periodontitis and healthy people before and after 
the first phase of periodontal therapy.  
As mentioned before, according to the relationship 
between IL-23 and IL-17, the null hypothesis is that, 
the amount of interleukins increases in periodentitis 
which is an inflammatory process; also, following the 
first phase of periodontal therapy, the amount of 
interleukins decreases along with gingival 
inflammation reduction. 
 
 
Methods 
In this clinical trial, intervention study, data 
collection was performed by a dentistry student under 
the superivision of a periodontologist. In order to avoid 
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bias at the time of conducting the final tests, the 
samples were coded so that neither the operator, nor 
the observer would be aware of the nature of the 
samples under study.  
For gathering GCF samples, the subjects were 
selected from the patients referred for dental treatment 
to the Dental School of Islamic Azad University 
Tehran and Shahid Beheshti Dental School in 2008-
2009; treatment was carried out by selecting the 
available samples to enter into the study after obtaining 
their consent (by signing the enclosed letter of consent) 
for participating in the study.  
The eligible cases included the patients who had 
generalized severe periodontitis diagnosed by 
measuring CAL (clinical attachment loss) and 
examining BOP (bleeding on probing). In the 25 
patients with a minimum of 15 teeth including at least 
10 posterior teeth; probing was performed on the 6 
points of each tooth: mesiobuccal, distobuccal, 
mesiolingual, lingual and distolingual. In more than 30 
areas, clinical attachment loss≥5 positive result of the 
diagnostic test BOP, was diagnozed as severe chronic 
periodontitis. In control group, periodontally healthy 
persons without any clear and stable gingival 
inflammation with CAL<1 and positive BOP were 
selected. 
The exclusion criteria were patients that used 
antibiotics and immunosuppressive drugs (cyclosporine 
A, corticosteroids) and NSAIDS within the last 6 
months, smoking during the recent 3 months, drug 
addiction within the last 3 months, diabetes, pregnancy 
and systemic diseases affecting the periodontium. Two 
GCF samples of all cases were gathered from the sites 
with the following features:  
Case group: CAL≥5 mm in patients with severe 
periodontitis (area of posterior teeth) 
Control group: CAL<1 and without any 
periodontal inflammation in healthy persons (BOP 
negative) 
Moreover, the samples were not gathered from the 
restored the teeth, teeth with prosthesis restorations, 
decayed teeth, teeth with occlusal interventions 
(premature contact in the centric or lateral and 
protrusive occlusion) and hopeless teeth. 
The members of the control group were equal to the 
case group in number and were selected from the 
persons referred to the university without periodontal 
disease. The age and sex of the cases were matched in 
case and control groups. In order to gather GCF, the 
selected sites were isolated; saliva and gingival plaques 
were removed by a rubber cup and a scaler. The 
periostrips were placed inside the gingival sulcus of the 
teeth for 30 seconds. The strips with visible signs of 
blood or saliva were excluded from the study. Then, 
the periostrips were placed in a microtube and first 
kept under -20
0c
.  
After collecting the required number of samples, 
200µl BPs was added to all microtubes and after that, 
they were centrifuged at 10000 rpm for 30 minutes; 
then, the periostrips were removed and the solutions 
were kept at -70°C until ELISA test were performed. 
Then, the first phase of periodontal therapy (scaling & 
root planning and oral hygiene control) was performed 
and the cases were called for re-sampling after 4 
weeks. The said steps for gathering GCF from the areas 
of taking the first samples were repeated.  
After making the required coordination with the 
laboratory in Shahid Beheshti University, the samples 
were forwarded for ELISA test and the amount of 
interleukins 17 and 23 was determined. The data 
obtained from the laboratory findings were the basis 
for statistical analyses. After performing Tukey test, it 
was found that the variables did not have a normal 
distribution. Therefore, the nonparametric tests were 
used for comparing the groups (Mann-Whitney U test). 
Spearman correlation coefficient test was used to 
determine the correlation between the variables. The 
criteria for statistical tests were considered according 
to the p-value≤0.05. 
 
 
Results 
In table 1, descriptive statistical analyses were 
provided for age, CAL, PD, IL-17 and IL-23 before 
and after the treatment and the correlation between the 
following in the case (chronic periodontitis) and 
control groups, respectively. 
The mean IL-17 saturation in case group was 30.27, 
and 17.29 for control group before the treatment and 
there was a significant difference between the two 
groups (p<0.005). The mean IL-17 saturation after the 
treatment was 27.66 for case, and 19.6 for control 
group. There was a significant difference between the 
two groups before and after the treatment (p<0.005). 
The mean IL-23 density was 33.77 and 14.08 
before treatment and 28.93 and 18.52 after treatment 
for the case and control groups. Moreover, there was a 
significant difference between IL-17 and IL-23 
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saturation before and after therapy in the case group 
(p<0.05).  
However, such a significant difference was not 
observed in the control group. In case group, there was 
a significant correlation between CAL and age 
(p<0.05), CAL and IL-17 saturation before therapy 
(p<0.005), IL-17 and IL-23 before therapy (p<0.005) 
and IL-23 saturation before and after therapy 
(p<0.005). However, the correlation between CAL and 
age was negative and positive in other cases. In control 
group, there was only a negative correlation between 
CAL and IL-17 saturation before therapy (p<0.05) and 
no significant statistical correlations existed among the 
variables of the control group (figure 1, 2).  
 
Table 1. Descriptive statistical analyses for age, CAL, PD, amount of IL-17 and IL-23  
before and after therapy 
 
Indices Variables Number Minimum Maximum Mean 
Standard 
deviation 
Age (Case group) 22 45 62 51.45 5.12 
Age (Control group) 24 40 55 48.75 4.00 
CAL
*
 (Case group) 22 5 7 5.77 0.51 
CAL (Control group) 24 0 1 0.42 0.41 
PD
**
 (Case group) 22 3 7 5.14 1.16 
PD (Control group) 24 1 3 1.83 0.70 
IL-17 before therapy (Case group) 22 0.40 1.60 0.93 0.48 
IL-17 before therapy (Control group) 24 0.38 1.60 0.54 0.24 
IL-17 after therapy (Case group) 22 0.30 0.70 0.40 0.12 
IL-17 after therapy (Control group) 24 0.3 0.4 0.32 0.03 
IL-23 before therapy (Case group) 22 64.00 290.00 113.00 64.37 
IL-23 before therapy (Control group) 24 59.00 89.00 64.25 8.29 
IL-23 after therapy (Case group) 22 39.00 62.00 53.41 9.32 
IL-23 after therapy (Control group) 24 39.00 59.00 45.71 8.06 
      *CAL: Clinical Attachment Loss 
      ** PD: Pocket Depth 
 
 
 
 
 
 
 
 
 
 
 
 
  Figure 1. Level of IL-17 before and after treatment           Figure 2. Level of IL-23 before and after treatment 
 
 
Discussion 
The present research revealed that IL-17, and IL 23 
amounts are significantly higher in cases with 
moderate to severe chronic periodontitis. Vernal et al. 
demonstrated an increase in IL-17 amounts in GCF 
samples and the surface fluid of gingival cells culture 
in chronic periodontitis (5). Honda et al. mentioned 
that the expression of IL-17 and IL-23 in periodontitis  
 
 
cases is relatively higher and they suggested a new idea 
on periodontal disease pathogenesis considering the 
role of T cells (6). Ohyama et al.
 
said that IL-17, and 
IL-23 expressions in periodontal lesions, particularly 
the regions adjacent to bone loss were significantly 
higher than the norml sites and they concluded that the 
activity and stimulation of Th17 cells could be 
observed in periodontal inflammatory lesions (7). In 
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the study of Cardoso et al. in 2009, an increase in 
expression and presence of IL-17, 23, 6, IL-1β and 
TGF-β in chronic periodontitis was reported. 
Therefore, they considered an important role for Th17 
cells in periodontal disease pathogenesis (8).
 
Evidently, there is a great compatibility between 
the findings and results obtained from the mentioned 
studies. We also found that the presence of IL-17 and 
IL-23 (as the most important cytokines inducing T cells 
distinction) was considerable. 
Avani et al. mentioned that an increase in IL-18 
amounts in GCF was seen in periodontal cases while 
IL-17 was not observed in any of the cases under 
study. Therefore, contrary to IL-17, IL-18 as an 
appropriate inflammatory index, was considered 
important (9). The difference between the findings and 
results gained from the mentioned study could be due 
to the following reasons: a) Difference in laboratory 
methods: in the mentioned study, GCF samples were 
gathered by Microcapillary pipettes on the gingival 
sulcus entry while periopaper or periostrips were used 
in our study. Furthermore, considering the fact that at 
least 50µl of samples would be needed for each ELISA 
test, the method of providing at least 100µl (for 
measuring IL-17, 18) out of the 1µl volume was not 
specified in the mentioned study) and since the 
mentioned study was carried out in India, racial 
differences might also be significant. 
We also found that even after the therapy, the 
density difference in the case group remains 
significantly higher than the control group. Moreover, 
we specified that the difference between IL-17 density 
before and after therapy and IL-23 density before and 
after therapy in the case group was statistically 
meaningful. According to the available sources, no 
studies have been conducted on the effect of therapy in 
IL-17 or IL-23 density changes after therapy; thus, 
studies exclusively performed on the effect of 
periodontal therapy on other cytokines are presented 
below. 
Thunell et al. expressed that primary periodontal 
therapy would lead to a decrease in the density of IL-
1α, β, IL-2, 3, 6, 7, 8, 12 and CCL5(10). Lopes et al. 
reported that following root planning and scaling in 
chronic periodontal cases, no meaningful difference for 
IL-1β density was seen before and after therapy (11). 
As mentioned before, in the present study, different 
cytokines, preferably those associated with IL-17, were 
studied and hence, they would have a significant role in 
the specific immune section. In a study conducted by 
Lopes etal. only IL-1β was studied IL-1β is produced 
by almost all inflammatory cells and it has a 
remarkable role in severe (and not chronic) 
inflammation. The study of Thunell et al. is similar to 
our study in the way how cytokines play a role in 
specific defense and provide Th1 responses (like IL-2, 
10). Tsai et al. Reported that IFN-δ density reduction 
and IL-4 density increase were seen following non-
surgical primary periodontal therapy (12).  
Although different cytokines are studied in the said 
study, it might be similar to our study in a way that a 
kind of reduction in Th1 activity and Th2 cells activity 
increase is referred to a reduction in IFN-δ density 
reduction (one of the most important Th1 cytokines) 
and IL-4 density increase (as one of the most important 
Th2 cytokines). This implies the change in Th cells 
balance. We also found that IL-17 and IL 23 densities 
reduce following therapy. 
In addition, in the present study, it was found that 
there is a meaningful correlation between CAL and IL-
17 density before treatment in the control group 
(p<0.05). In the case group, IL-17 and IL 23 densities 
are meaningfully correlated before and after therapy 
(p<0.005). Since there were no similar articles 
available in this field, the findings could not be 
compared with any other studies. 
 
 
Conclusion 
According to the results of the present study, the 
first phase of periodontal therapy can decrease the 
amount of inflammatory cytokines and therefore plays 
a significant role in periodontitis treatment, bone loss 
reduction and gingival tissue recovery. 
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